Penicillin, the first antibiotic to be discovered, has saved millions of lives since it was introduced in the 1940s. However, some bacteria have developed resistance to penicillin, making it less effective in treating certain infections.
The new research, published in the journal Nature Communications, reveals how penicillin works at the molecular level. This knowledge could help scientists design new antibiotics that are more effective at killing bacteria, including those that are resistant to penicillin.
"This is a major breakthrough in our understanding of how penicillin works," said lead researcher Dr. James Spencer, a professor of biochemistry at the University of Cambridge. "This discovery could lead to the development of new antibiotics that are more effective and less likely to cause resistance."
Penicillin works by interfering with the synthesis of a molecule called peptidoglycan, which is an important component of the bacterial cell wall. By inhibiting the synthesis of peptidoglycan, penicillin weakens the cell wall and causes the bacterial cell to break open and die.
The new research reveals that penicillin binds to a specific enzyme called transpeptidase, which is involved in the synthesis of peptidoglycan. By binding to transpeptidase, penicillin blocks the enzyme from functioning and prevents the synthesis of peptidoglycan.
"This is the first time that we have been able to see how penicillin binds to transpeptidase and inhibits its activity," said Dr. Spencer. "This information could be used to design new antibiotics that are more potent and less likely to cause resistance."
The researchers are now working to develop new antibiotics based on the new information. They believe that these antibiotics could be more effective at treating bacterial infections, including those that are resistant to penicillin.
"We are excited about the potential of this research to lead to new antibiotics that can help us fight the growing problem of bacterial resistance," said Dr. Spencer. "Penicillin has been a lifesaver for millions of people, and we hope that our research will help to develop even better antibiotics that will continue to save lives."